{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/MARIA",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalTool/0.6-DRAFT",
      "sc:additionalType": "Web application",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_2830"
        },
        {
          "@id": "edam:topic_3474"
        },
        {
          "@id": "edam:topic_2640"
        },
        {
          "@id": "edam:topic_0121"
        },
        {
          "@id": "edam:topic_0154"
        }
      ],
      "sc:citation": [
        {
          "@id": "https://doi.org/10.1038/S41587-019-0280-2"
        },
        "pubmed:31611695"
      ],
      "sc:description": "Predicting HLA class II antigen presentation through integrated deep learning.\n\nMARIA is a machine learning tool developed by Chen et al. to predict likelihood of HLA-II peptide ligand presentation given cell HLA alleles, peptide sequences, and source genes of the peptides.",
      "sc:featureList": [
        {
          "@id": "edam:operation_2454"
        },
        {
          "@id": "edam:operation_0416"
        },
        {
          "@id": "edam:operation_0252"
        },
        {
          "@id": "edam:operation_3439"
        }
      ],
      "sc:name": "MARIA",
      "sc:url": "https://maria.stanford.edu/"
    },
    {
      "@id": "https://doi.org/10.1038/S41587-019-0280-2",
      "@type": "sc:CreativeWork"
    }
  ]
}